Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 343Other hematologic neoplasm 299Plasma cell 115Sarcoma 111Myeloid 101CNS 100Breast 93Genitourinary 59Gynecologic 53Classical hematology 41Dermatologic 38Thoracic 25Other solid neoplasm 25Gastrointestinal 21Head & Neck 18Endocrine 7Other neoplasm 2NET 2Tumor-Agnostic 1Other 1

Conditions

Xerostomia 1Squamous Cell Carcinoma of Head and Neck 1Mucositis 1Head and Neck Neoplasms 1

Interventions

Exercise 28Metformin 24Surveys and Questionnaires 19Radiotherapy 14Methods 14Early Intervention, Educational 13Counseling 13Educational Status 12naloxegol 10Standard of Care 10Tirzepatide 9Nutrition Assessment 9Diet Therapy 9Cisplatin 9Resistance Training 8Psychiatric Rehabilitation 8Diet 8Therapeutics 7Interviews as Topic 7alvimopan 6Liraglutide 6Fibroblast Growth Factor 7 6Caloric Restriction 6semaglutide 5Radiation 5Low-Level Light Therapy 5Injections 5Exenatide 5Diet, Mediterranean 5Dexamethasone 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Filgrastim × Other × Clear all
NCT00352118 2017-12-28

Combination Chemotherapy and Radiation Therapy in Treating Patients With Locally Advanced Head and Neck Cancer

Masonic Cancer Center, University of Minnesota

Phase 2 Terminated
4 enrolled 4 charts
Head & NeckOther

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms, Xerostomia, Mucositis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡